Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Molecular and Cellular Pediatrics
Published in: Molecular and Cellular Pediatrics 1/2024

Open Access 01-12-2024 | Bronchial Asthma | Review

The role of regulatory B cells in immune regulation and childhood allergic asthma

Authors: Caroline Vanessa Kliem, Bianca Schaub

Published in: Molecular and Cellular Pediatrics | Issue 1/2024

Login to get access

Abstract

Background

As the most common chronic disease in childhood, asthma displays a major public health problem worldwide with the incidence of those affected rising. As there is currently no cure for allergic asthma, it is mandatory to get a better understanding of the underlying molecular mechanism.

Main body

By producing IgE antibodies upon allergen contact, B cells play a pivotal role in allergic asthma. Besides that, IL-10-secreting B cell subsets, namely regulatory B cells (Bregs), are reported in mice and humans to play a role in allergic asthma. In humans, several Breg subsets with distinct phenotypic and functional properties are identified among B cells at different maturational and differentiation stages that exert anti-inflammatory functions by expressing several suppressor molecules. Emerging research has focused on the role of Bregs in allergic asthma as well as their role for future diagnostic and preventive strategies.

Conclusion

Knowledge about the exact function of human Bregs in allergic asthma is still very limited. This review aims to summarize the current knowledge on Bregs. We discuss different human Breg subsets, several ways of Breg induction as well as the mechanisms through which they exert immunoregulatory functions, and their role in (childhood) allergic asthma.
Literature
1.
Castagnoli R, Brambilla I, Giovannini M, Marseglia GL, Licari A (2023) New approaches in childhood asthma treatment. Curr Opin Allergy Clin Immunol 23(4):319–326PubMedPubMedCentralCrossRef
2.
Fainardi V, Esposito S, Chetta A, Pisi G (2022) Asthma phenotypes and endotypes in childhood. Minerva Med 113(1):94–105PubMedCrossRef
3.
Vos T et al. (2020) Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 396(10258):1204–22
4.
Masoli M, Fabian D, Holt S, Beasley R (2004) The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 59(5):469–478PubMedCrossRef
5.
El-Husseini ZW, Gosens R, Dekker F, Koppelman GH (2020) The genetics of asthma and the promise of genomics-guided drug target discovery. Lancet Respir Med 8(10):1045–1056PubMedCrossRef
6.
Salvermoser M, Zeber K, Boeck A, Klucker E, Schaub B (2021) Childhood asthma: novel endotyping by cytokines, validated through sensitization profiles and clinical characteristics. Clin Exp Allergy 51(5):654–665PubMedCrossRef
7.
Bousquet J, Hellings PW, Agache I, Bedbrook A, Bachert C, Bergmann KC et al (2016) ARIA 2016: care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle. Clin Transl Allergy 6:47PubMedPubMedCentralCrossRef
8.
Janeway C (2005) Immunobiology: the immune system in health and disease, 6th edn. Garland Science, New York
9.
van de Veen W, Stanic B, Wirz OF, Jansen K, Globinska A, Akdis M (2016) Role of regulatory B cells in immune tolerance to allergens and beyond. J Allergy Clin Immunol 138(3):654–665PubMedCrossRef
10.
Akdis M, Akdis CA (2009) Therapeutic manipulation of immune tolerance in allergic disease. Nat Rev Drug Discov 8(8):645–660PubMedCrossRef
11.
Pieper K, Grimbacher B, Eibel H (2013) B-cell biology and development. J Allergy Clin Immunol 131(4):959–971PubMedCrossRef
12.
Jansen K, Cevhertas L, Ma S, Satitsuksanoa P, Akdis M, van de Veen W (2021) Regulatory B cells. A to Z Allergy 76(9):2699–2715CrossRef
13.
14.
15.
Blair PA, Noreña LY, Flores-Borja F, Rawlings DJ, Isenberg DA, Ehrenstein MR et al (2010) CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients. Immunity 32(1):129–140PubMedCrossRef
16.
Matsumoto M, Baba A, Yokota T, Nishikawa H, Ohkawa Y, Kayama H et al (2014) Interleukin-10-producing plasmablasts exert regulatory function in autoimmune inflammation. Immunity 41(6):1040–1051PubMedCrossRef
17.
Akdis CA, Arkwright PD, Brüggen M-C, Busse W, Gadina M, Guttman-Yassky E et al (2020) Type 2 immunity in the skin and lungs. Allergy 75(7):1582–1605PubMedCrossRef
18.
Habener A, Happle C, Grychtol R, Skuljec J, Busse M, Dalüge K et al (2021) Regulatory B cells control airway hyperreactivity and lung remodeling in a murine asthma model. J Allergy Clin Immunol 147(6):2281-2294.e7PubMedCrossRef
19.
Habener A, Grychtol R, Gaedcke S, DeLuca D, Dittrich AM, Happle C et al (2022) IgA+ memory B-cells are significantly increased in patients with asthma and small airway dysfunction. Eur Respir J 60(5):2102130
20.
Oliveria J-P, El-Gammal AI, Yee M, Obminski CD, Scime TX, Watson RM et al (2018) Changes in regulatory B-cell levels in bone marrow, blood, and sputum of patients with asthma following inhaled allergen challenge. J Allergy Clin Immunol 141(4):1495-1498.e9PubMedCrossRef
21.
Miyajima S, Shigehara K, Kamekura R, Takaki H, Yabe H, Ikegami I et al (2020) Activated circulating T follicular helper cells and skewing of T follicular helper 2 cells are down-regulated by treatment including an inhaled corticosteroid in patients with allergic asthma. Allergol Int 69(1):66–77PubMedCrossRef
22.
Wiest M, Upchurch K, Hasan MM, Cardenas J, Lanier B, Millard M et al (2019) Phenotypic and functional alterations of regulatory B cell subsets in adult allergic asthma patients. Clin Exp Allergy 49(9):1214–1224PubMedCrossRef
23.
Sheehan WJ, Maghzian N, Rastogi D, Bollard CM, Lin AA (2023) Decreased regulatory B cells in pediatric patients with asthma. Ann Allergy Asthma Immunol 131(1):120–121PubMedCrossRef
24.
Krusche J, Basse S, Schaub B (2020) Role of early life immune regulation in asthma development. Semin Immunopathol 42(1):29–42PubMedCrossRef
25.
Akdis M, Aab A, Altunbulakli C, Azkur K, Costa RA, Crameri R et al (2016) Interleukins (from IL-1 to IL-38), interferons, transforming growth factor β, and TNF-α: receptors, functions, and roles in diseases. J Allergy Clin Immunol 138(4):984–1010PubMedCrossRef
26.
Oliveria JP, Agayby R, Gauvreau GM (2021) Regulatory and IgE+ B cells in allergic asthma. Methods Mol Biol 2270:375–418PubMedCrossRef
27.
28.
Wills-Karp M (1999) Immunologic basis of antigen-induced airway hyperresponsiveness. Annu Rev Immunol 17:255–281PubMedCrossRef
29.
30.
Smith SG, Gauvreau GM (2007) IL-13 is a novel therapeutic target in allergic asthma. Expert Rev Clin Immunol 3(5):671–675PubMedCrossRef
31.
Stoltz DJ, Jackson DJ, Evans MD, Gangnon RE, Tisler CJ, Gern JE et al (2013) Specific patterns of allergic sensitization in early childhood and asthma & rhinitis risk. Clin Exp Allergy 43(2):233–241PubMedPubMedCentralCrossRef
32.
Moon H-G, Kim S-J, Lee MK, Kang H, Choi HS, Harijith A et al (2020) Colony-stimulating factor 1 and its receptor are new potential therapeutic targets for allergic asthma. Allergy 75(2):357–369PubMedCrossRef
33.
Matsushita T, Yanaba K, Bouaziz J-D, Fujimoto M, Tedder TF (2008) Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J Clin Invest 118(10):3420–3430PubMedPubMedCentral
34.
Watanabe R, Ishiura N, Nakashima H, Kuwano Y, Okochi H, Tamaki K et al (2010) Regulatory B cells (B10 cells) have a suppressive role in murine lupus: CD19 and B10 cell deficiency exacerbates systemic autoimmunity. J Immunol 184(9):4801–4809PubMedCrossRef
35.
Jurlander J, Lai C-F, Tan J, Chou C-C, Geisler CH, Schriber J et al (1997) Characterization of interleukin-10 receptor expression on B-cell chronic lymphocytic leukemia cells. Blood 89(11):4146–4152PubMedCrossRef
36.
Hulse KE, Norton JE, Suh L, Zhong Q, Mahdavinia M, Simon P et al (2013) Chronic rhinosinusitis with nasal polyps is characterized by B-cell inflammation and EBV-induced protein 2 expression. J Allergy Clin Immunol 131(4):1075–83 (1083.e1-7)PubMedPubMedCentralCrossRef
37.
Amu S, Saunders SP, Kronenberg M, Mangan NE, Atzberger A, Fallon PG (2010) Regulatory B cells prevent and reverse allergic airway inflammation via FoxP3-positive T regulatory cells in a murine model. J Allergy Clin Immunol 125(5):1114-1124.e8PubMedCrossRef
38.
39.
Eibel H, Kraus H, Sic H, Kienzler A-K, Rizzi M (2014) B cell biology: an overview. Curr Allergy Asthma Rep 14(5):434PubMedCrossRef
40.
Ghia P, ten Boekel E, Rolink AG, Melchers F (1998) B-cell development: a comparison between mouse and man. Immunol Today 19(10):480–485PubMedCrossRef
41.
Chung JB, Silverman M, Monroe JG (2003) Transitional B cells: step by step towards immune competence. Trends Immunol 24(6):343–349PubMedCrossRef
42.
Palanichamy A, Barnard J, Zheng B, Owen T, Quach T, Wei C et al (2009) Novel human transitional B cell populations revealed by B cell depletion therapy. J Immunol 182(10):5982–5993PubMedCrossRef
43.
Batten M, Groom J, Cachero TG, Qian F, Schneider P, Tschopp J et al (2000) BAFF mediates survival of peripheral immature B lymphocytes. J Exp Med 192(10):1453–1466PubMedPubMedCentralCrossRef
44.
45.
Good KL, Avery DT, Tangye SG (2009) Resting human memory B cells are intrinsically programmed for enhanced survival and responsiveness to diverse stimuli compared to naive B cells. J Immunol 182(2):890–901PubMedCrossRef
46.
Harris DP, Haynes L, Sayles PC, Duso DK, Eaton SM, Lepak NM et al (2000) Reciprocal regulation of polarized cytokine production by effector B and T cells. Nat Immunol 1(6):475–482PubMedCrossRef
47.
Allen CDC (2022) Features of B cell responses relevant to allergic disease. J Immunol 208(2):257–266PubMedCrossRef
48.
Wypych TP, Marzi R, Wu GF, Lanzavecchia A, Sallusto F (2018) Role of B cells in TH cell responses in a mouse model of asthma. J Allergy Clin Immunol 141(4):1395–1410PubMedCrossRef
49.
Dullaers M, Schuijs MJ, Willart M, Fierens K, van Moorleghem J, Hammad H et al (2017) House dust mite-driven asthma and allergen-specific T cells depend on B cells when the amount of inhaled allergen is limiting. J Allergy Clin Immunol 140(1):76-88.e7PubMedCrossRef
50.
Korsgren M, Erjefält JS, Korsgren O, Sundler F, Persson CG (1997) Allergic eosinophil-rich inflammation develops in lungs and airways of B cell-deficient mice. J Exp Med 185(5):885–892PubMedPubMedCentralCrossRef
51.
Katz SI, Parker D, Turk JL (1974) B-cell suppression of delayed hypersensitivity reactions. Nature 251(5475):550–551PubMedCrossRef
52.
Neta R, Salvin SB (1974) Specific suppression of delayed hypersensitivity: the possible presence of a suppressor B cell in the regulation of delayed hypersensitivity. J Immunol 113(6):1716–1725PubMedCrossRef
53.
Palomares O, Akdis M, Martín-Fontecha M, Akdis CA (2017) Mechanisms of immune regulation in allergic diseases: the role of regulatory T and B cells. Immunol Rev 278(1):219–236PubMedCrossRef
54.
Mizoguchi A, Mizoguchi E, Takedatsu H, Blumberg RS, Bhan AK (2002) Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity 16(2):219–230PubMedCrossRef
55.
Fillatreau S, Sweenie CH, McGeachy MJ, Gray D, Anderton SM (2002) B cells regulate autoimmunity by provision of IL-10. Nat Immunol 3(10):944–950PubMedCrossRef
56.
57.
58.
Goetz M, Atreya R, Ghalibafian M, Galle PR, Neurath MF (2007) Exacerbation of ulcerative colitis after rituximab salvage therapy. Inflamm Bowel Dis 13(11):1365–1368PubMedCrossRef
59.
Dass S, Vital EM, Emery P (2007) Development of psoriasis after B cell depletion with rituximab. Arthritis Rheum 56(8):2715–2718PubMedCrossRef
60.
Iwata Y, Matsushita T, Horikawa M, Dilillo DJ, Yanaba K, Venturi GM et al (2011) Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells. Blood 117(2):530–541PubMedPubMedCentralCrossRef
61.
Flores-Borja F, Bosma A, Ng D, Reddy V, Ehrenstein MR, Isenberg DA et al (2013) CD19+CD24hiCD38hi B cells maintain regulatory T cells while limiting TH1 and TH17 differentiation. Sci Transl Med 5(173):173ra23PubMedCrossRef
62.
Das A, Ellis G, Pallant C, Lopes AR, Khanna P, Peppa D et al (2012) IL-10-producing regulatory B cells in the pathogenesis of chronic hepatitis B virus infection. J Immunol 189(8):3925–3935PubMedCrossRef
63.
van de Veen W, Stanic B, Yaman G, Wawrzyniak M, Söllner S, Akdis DG et al (2013) IgG4 production is confined to human IL-10-producing regulatory B cells that suppress antigen-specific immune responses. J Allergy Clin Immunol 131(4):1204–1212PubMedCrossRef
64.
Shalapour S, Font-Burgada J, Di Caro G, Zhong Z, Sanchez-Lopez E, Dhar D et al (2015) Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy. Nature 521(7550):94–98PubMedPubMedCentralCrossRef
65.
Lindner S, Dahlke K, Sontheimer K, Hagn M, Kaltenmeier C, Barth TFE et al (2013) Interleukin 21-induced granzyme B-expressing B cells infiltrate tumors and regulate T cells. Cancer Res 73(8):2468–2479PubMedCrossRef
66.
Brosseau C, Durand M, Colas L, Durand E, Foureau A, Cheminant M-A et al (2018) CD9+ regulatory B cells induce T cell apoptosis via IL-10 and are reduced in severe asthmatic patients. Front Immunol 9:3034PubMedPubMedCentralCrossRef
67.
Zhang M, Zheng X, Zhang J, Zhu Y, Zhu X, Liu H et al (2012) CD19(+)CD1d(+)CD5(+) B cell frequencies are increased in patients with tuberculosis and suppress Th17 responses. Cell Immunol 274(1–2):89–97PubMedCrossRef
68.
Zhang M, Zeng G, Yang Q, Zhang J, Zhu X, Chen Q et al (2014) Anti-tuberculosis treatment enhances the production of IL-22 through reducing the frequencies of regulatory B cell. Tuberculosis (Edinb) 94(3):238–244PubMedCrossRef
69.
Menon M, Blair PA, Isenberg DA, Mauri C (2016) A regulatory feedback between plasmacytoid dendritic cells and regulatory B cells is aberrant in systemic lupus erythematosus. Immunity 44(3):683–697PubMedPubMedCentralCrossRef
70.
Rosser EC, Oleinika K, Tonon S, Doyle R, Bosma A, Carter NA et al (2014) Regulatory B cells are induced by gut microbiota-driven interleukin-1β and interleukin-6 production. Nat Med 20(11):1334–1339PubMedCrossRef
71.
Yoshizaki A, Miyagaki T, Dilillo DJ, Matsushita T, Horikawa M, Kountikov EI et al (2012) Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions. Nature 491(7423):264–268PubMedPubMedCentralCrossRef
72.
Giordani L, Sanchez M, Libri I, Quaranta MG, Mattioli B, Viora M (2009) IFN-alpha amplifies human naive B cell TLR-9-mediated activation and Ig production. J Leukoc Biol 86(2):261–271PubMedCrossRef
73.
Jego G, Palucka AK, Blanck J-P, Chalouni C, Pascual V, Banchereau J (2003) Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6. Immunity 19(2):225–234PubMedCrossRef
74.
Ramgolam VS, Sha Y, Marcus KL, Choudhary N, Troiani L, Chopra M et al (2011) B cells as a therapeutic target for IFN-β in relapsing-remitting multiple sclerosis. J Immunol 186(7):4518–4526PubMedCrossRef
75.
Liu B-S, Cao Y, Huizinga TW, Hafler DA, Toes REM (2014) TLR-mediated STAT3 and ERK activation controls IL-10 secretion by human B cells. Eur J Immunol 44(7):2121–2129PubMedCrossRef
76.
Yu C-R, Choi JK, Uche AN, Egwuagu CE (2018) Production of IL-35 by Bregs is mediated through binding of BATF-IRF-4-IRF-8 complex to il12a and ebi3 promoter elements. J Leukoc Biol 104(6):1147–1157PubMedCrossRef
77.
Yanaba K, Bouaziz J-D, Haas KM, Poe JC, Fujimoto M, Tedder TF (2008) A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity 28(5):639–650PubMedCrossRef
78.
Yanaba K, Bouaziz J-D, Matsushita T, Tsubata T, Tedder TF (2009) The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals. J Immunol 182(12):7459–7472PubMedCrossRef
79.
Haas KM, Watanabe R, Matsushita T, Nakashima H, Ishiura N, Okochi H et al (2010) Protective and pathogenic roles for B cells during systemic autoimmunity in NZB/W F1 mice. J Immunol 184(9):4789–4800PubMedCrossRef
80.
Stanic B, van de Veen W, Wirz OF, Rückert B, Morita H, Söllner S et al (2015) IL-10-overexpressing B cells regulate innate and adaptive immune responses. J Allergy Clin Immunol 135(3):771–80.e8PubMedCrossRef
81.
Piper CJM, Rosser EC, Oleinika K, Nistala K, Krausgruber T, Rendeiro AF et al (2019) Aryl hydrocarbon receptor contributes to the transcriptional program of IL-10-producing regulatory B cells. Cell Rep 29(7):1878-1892.e7PubMedPubMedCentralCrossRef
82.
Fehres CM, van Uden NO, Yeremenko NG, Fernandez L, Franco Salinas G, van Duivenvoorde LM et al (2019) APRIL induces a novel subset of IgA+ regulatory B cells that suppress inflammation via expression of IL-10 and PD-L1. Front Immunol 10:1368PubMedPubMedCentralCrossRef
83.
Komlósi ZI, Kovács N, van de Veen W, Kirsch AI, Fahrner HB, Wawrzyniak M et al (2018) Human CD40 ligand-expressing type 3 innate lymphoid cells induce IL-10-producing immature transitional regulatory B cells. J Allergy Clin Immunol 142(1):178-194.e11PubMedCrossRef
84.
Wang R-X, Yu C-R, Dambuza IM, Mahdi RM, Dolinska MB, Sergeev YV et al (2014) Interleukin-35 induces regulatory B cells that suppress autoimmune disease. Nat Med 20(6):633–641PubMedPubMedCentralCrossRef
85.
van der Vlugt LEPM, Labuda LA, Ozir-Fazalalikhan A, Lievers E, Gloudemans AK, Liu K-Y et al (2012) Schistosomes induce regulatory features in human and mouse CD1d(hi) B cells: inhibition of allergic inflammation by IL-10 and regulatory T cells. PLoS ONE 7(2):e30883PubMedPubMedCentralCrossRef
86.
Parekh VV, Prasad DVR, Banerjee PP, Joshi BN, Kumar A, Mishra GC (2003) B cells activated by lipopolysaccharide, but not by anti-Ig and anti-CD40 antibody, induce anergy in CD8+ T cells: role of TGF-beta 1. J Immunol 170(12):5897–5911PubMedCrossRef
87.
Rosser EC, Mauri C (2015) Regulatory B cells: origin, phenotype, and function. Immunity 42(4):607–612PubMedCrossRef
88.
Shen P, Roch T, Lampropoulou V, O’Connor RA, Stervbo U, Hilgenberg E et al (2014) IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases. Nature 507(7492):366–370PubMedPubMedCentralCrossRef
89.
Palomares O, Martín-Fontecha M, Lauener R, Traidl-Hoffmann C, Cavkaytar O, Akdis M et al (2014) Regulatory T cells and immune regulation of allergic diseases: roles of IL-10 and TGF-β. Genes Immun 15(8):511–520PubMedCrossRef
90.
Reißig S, Tang Y, Nikolaev A, Gerlach K, Wolf C, Davari K et al (2017) Elevated levels of Bcl-3 inhibits Treg development and function resulting in spontaneous colitis. Nat Commun 8:15069PubMedPubMedCentralCrossRef
91.
Riemann M, Endres R, Liptay S, Pfeffer K, Schmid RM (2005) The IkappaB protein Bcl-3 negatively regulates transcription of the IL-10 gene in macrophages. J Immunol 175(6):3560–3568PubMedCrossRef
92.
Carmody RJ, Ruan Q, Palmer S, Hilliard B, Chen YH (2007) Negative regulation of toll-like receptor signaling by NF-kappaB p50 ubiquitination blockade. Science 317(5838):675–678PubMedCrossRef
93.
Zhang X, Wang H, Claudio E, Brown K, Siebenlist U (2007) A role for the IκB family member Bcl-3 in the control of central immunologic tolerance. Immunity 27(3):438–452PubMedPubMedCentralCrossRef
94.
Francisco LM, Salinas VH, Brown KE, Vanguri VK, Freeman GJ, Kuchroo VK et al (2009) PD-L1 regulates the development, maintenance, and function of induced regulatory T cells. J Exp Med 206(13):3015–3029PubMedPubMedCentralCrossRef
95.
Khan AR, Hams E, Floudas A, Sparwasser T, Weaver CT, Fallon PG (2015) PD-L1hi B cells are critical regulators of humoral immunity. Nat Commun 6:5997PubMedCrossRef
96.
Klinker MW, Reed TJ, Fox DA, Lundy SK (2013) Interleukin-5 supports the expansion of fas ligand-expressing killer B cells that induce antigen-specific apoptosis of CD4(+) T cells and secrete interleukin-10. PLoS ONE 8(8):e70131PubMedPubMedCentralCrossRef
97.
Figueiró F, Muller L, Funk S, Jackson EK, Battastini AMO, Whiteside TL (2016) Phenotypic and functional characteristics of CD39high human regulatory B cells (Breg). Oncoimmunology 5(2):e1082703PubMedPubMedCentralCrossRef
98.
Ding Q, Yeung M, Camirand G, Zeng Q, Akiba H, Yagita H et al (2011) Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice. J Clin Invest 121(9):3645–3656PubMedPubMedCentralCrossRef
99.
Rosser EC, Piper CJM, Matei DE, Blair PA, Rendeiro AF, Orford M et al (2020) Microbiota-derived metabolites suppress arthritis by amplifying aryl-hydrocarbon receptor activation in regulatory B cells. Cell Metab 31(4):837-851.e10PubMedPubMedCentralCrossRef
100.
Neves P, Lampropoulou V, Calderon-Gomez E, Roch T, Stervbo U, Shen P et al (2010) Signaling via the MyD88 adaptor protein in B cells suppresses protective immunity during Salmonella typhimurium infection. Immunity 33(5):777–790PubMedCrossRef
101.
Noh J, Lee JH, Noh G, Bang SY, Kim HS, Choi WS et al (2010) Characterisation of allergen-specific responses of IL-10-producing regulatory B cells (Br 1) in Cow Milk Allergy. Cell Immunol 264(2):143–149PubMedCrossRef
102.
Braza F, Chesne J, Durand M, Dirou S, Brosseau C, Mahay G et al (2015) A regulatory CD9(+) B-cell subset inhibits HDM-induced allergic airway inflammation. Allergy 70(11):1421–1431PubMedCrossRef
103.
Qian G, Jiang W, Sun D, Sun Z, Chen A, Fang H et al (2023) B-cell-derived IL-10 promotes allergic sensitization in asthma regulated by Bcl-3. Cell Mol Immunol 20(11):1313–1327
104.
van der Vlugt LEPM, Mlejnek E, Ozir-Fazalalikhan A, Janssen Bonas M, Dijksman TR, Labuda LA et al (2014) CD24(hi)CD27(+) B cells from patients with allergic asthma have impaired regulatory activity in response to lipopolysaccharide. Clin Exp Allergy 44(4):517–528PubMedCrossRef
105.
Wirz OF, Głobińska A, Ochsner U, van de Veen W, Eller E, Christiansen ES et al (2019) Comparison of regulatory B cells in asthma and allergic rhinitis. Allergy 74(4):815–818PubMedCrossRef
Metadata
Title
The role of regulatory B cells in immune regulation and childhood allergic asthma
Authors
Caroline Vanessa Kliem
Bianca Schaub
Publication date
01-12-2024
Publisher
Springer International Publishing
Published in
Molecular and Cellular Pediatrics / Issue 1/2024
Electronic ISSN: 2194-7791
DOI
https://doi.org/10.1186/s40348-023-00174-2